Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir Avan

Showing results (31-40 of 462) with videos related to

Pageof 47
Sort By:
Current Pharmaceutical Design|April 10, 2025
Current Insights into Endometriosis: Hormonal Management, Clinical Outcomes, and Opportunities for ProgressMarzieh Neykhonji, Abdulridha Mohammed Al-Asady, Amir Avan, et al.
Current Pharmaceutical Design|September 26, 2022
Bacterial Peptides and Bacteriocins as a Promising Therapy for Solid TumorAtieh Yaghoubi, Kiarash Ghazvini, Seyed Mahdi Hasanian, et al.
Current Cancer Drug Targets|June 2, 2021
The Therapeutic Potential of Targeting Autophagy in the Treatment of CancerNegin Chaeichi-Tehrani, Gordon A Ferns, Seyed Mahdi Hassanian, et al.
EXCLI Journal|October 30, 2020
The association of a genetic variant in CDKN2A/B gene and the risk of colorectal cancerFarzad Rahmani, Amir Avan, Forouzan Amerizadeh, et al.
Journal of Pharmacopuncture|October 5, 2018
Auraptene Inhibits Migration and Invasion of Cervical and Ovarian Cancer Cells by Repression of Matrix Metalloproteinasas 2 and 9 ActivityKhadijeh Jamialahmadi, Sofia Salari, Nafiseh Sadat Alamolhodaei, et al.
Current Pharmaceutical Design|July 18, 2024
Nanotechnological Advances in the Diagnosis of Gynecological Cancers and NanotheranosticsVahideh Keyvani, Samaneh Mollazadeh, Espanta Riahi, et al.
Current Drug Targets|December 9, 2014
Synergistic activity of the c-Met and tubulin inhibitor tivantinib (ARQ197) with pemetrexed in mesothelioma cellsLeticia G Leon, Maria Gemelli, Rocco Sciarrillo, et al.
Current Drug Targets|November 11, 2014
Targeting c-MET/HGF signaling pathway in upper gastrointestinal cancers: rationale and progressSharareh Gholamin, Hamid Fiuji, Mina Maftouh, et al.
Current Pharmaceutical Design|November 6, 2023
Current use of Molecular Mechanisms and Signaling Pathways in Targeted Therapy of Prostate CancerVahideh Keyvani, Samaneh Mollazadeh, Nahid Kheradmand, et al.
Gene|February 12, 2020
Role of regulatory miRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancerFarzad Rahmani, Gordon A Ferns, Sahar Talebian, et al.
Pageof 47

Showing results (31-40 of 462) with videos related to

Sort By:
Pageof 47
Current Pharmaceutical Design|April 10, 2025
Current Insights into Endometriosis: Hormonal Management, Clinical Outcomes, and Opportunities for ProgressMarzieh Neykhonji, Abdulridha Mohammed Al-Asady, Amir Avan, et al.
Current Pharmaceutical Design|September 26, 2022
Bacterial Peptides and Bacteriocins as a Promising Therapy for Solid TumorAtieh Yaghoubi, Kiarash Ghazvini, Seyed Mahdi Hasanian, et al.
Current Cancer Drug Targets|June 2, 2021
The Therapeutic Potential of Targeting Autophagy in the Treatment of CancerNegin Chaeichi-Tehrani, Gordon A Ferns, Seyed Mahdi Hassanian, et al.
EXCLI Journal|October 30, 2020
The association of a genetic variant in CDKN2A/B gene and the risk of colorectal cancerFarzad Rahmani, Amir Avan, Forouzan Amerizadeh, et al.
Journal of Pharmacopuncture|October 5, 2018
Auraptene Inhibits Migration and Invasion of Cervical and Ovarian Cancer Cells by Repression of Matrix Metalloproteinasas 2 and 9 ActivityKhadijeh Jamialahmadi, Sofia Salari, Nafiseh Sadat Alamolhodaei, et al.
Current Pharmaceutical Design|July 18, 2024
Nanotechnological Advances in the Diagnosis of Gynecological Cancers and NanotheranosticsVahideh Keyvani, Samaneh Mollazadeh, Espanta Riahi, et al.
Current Drug Targets|December 9, 2014
Synergistic activity of the c-Met and tubulin inhibitor tivantinib (ARQ197) with pemetrexed in mesothelioma cellsLeticia G Leon, Maria Gemelli, Rocco Sciarrillo, et al.
Current Drug Targets|November 11, 2014
Targeting c-MET/HGF signaling pathway in upper gastrointestinal cancers: rationale and progressSharareh Gholamin, Hamid Fiuji, Mina Maftouh, et al.
Current Pharmaceutical Design|November 6, 2023
Current use of Molecular Mechanisms and Signaling Pathways in Targeted Therapy of Prostate CancerVahideh Keyvani, Samaneh Mollazadeh, Nahid Kheradmand, et al.
Gene|February 12, 2020
Role of regulatory miRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancerFarzad Rahmani, Gordon A Ferns, Sahar Talebian, et al.
Pageof 47